SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 135 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $208,000 | -86.0% | 34,200 | -87.3% | 0.14% | -72.9% |
| Q3 2016 | $1,484,000 | +45.1% | 269,300 | 0.0% | 0.51% | +23.7% |
| Q2 2016 | $1,023,000 | +37.7% | 269,300 | 0.0% | 0.41% | +32.8% |
| Q1 2016 | $743,000 | -51.3% | 269,300 | 0.0% | 0.31% | -28.2% |
| Q4 2015 | $1,527,000 | -43.0% | 269,300 | -46.7% | 0.43% | -16.4% |
| Q3 2015 | $2,680,000 | -62.5% | 505,600 | -41.3% | 0.51% | -23.9% |
| Q2 2015 | $7,148,000 | +76.9% | 861,200 | -1.5% | 0.67% | +76.4% |
| Q1 2015 | $4,041,000 | +48.1% | 874,600 | -2.3% | 0.38% | +45.8% |
| Q4 2014 | $2,729,000 | +9.5% | 894,800 | 0.0% | 0.26% | +1.9% |
| Q3 2014 | $2,492,000 | -35.4% | 894,800 | -5.7% | 0.26% | -22.4% |
| Q2 2014 | $3,860,000 | -23.5% | 948,500 | -0.2% | 0.33% | -19.7% |
| Q1 2014 | $5,044,000 | -7.5% | 950,000 | -1.9% | 0.41% | -7.8% |
| Q4 2013 | $5,452,000 | +26.6% | 968,400 | +2.8% | 0.45% | +11.2% |
| Q3 2013 | $4,306,000 | +4.1% | 942,200 | -1.6% | 0.40% | -4.7% |
| Q2 2013 | $4,137,000 | – | 957,700 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |